Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

4,269 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Pre-Amended PMNOC Regulations: Court Decisions On The Merits (Polymorph, Salt, Formulation Patents)

    There have been two Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations) decisions on the merits so far in 2019 and a pair of appeal decisions
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Principales nouvelles de l'année 2017 dans le secteur pharmaceutique

    Mes collègues Jillian Hyslop, Tracey Stott, Kristin Wall et Jordana Sanft ont fait un aperçu des principales nouvelles de l'année 2017 dans le secteur pharmaceutique.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Prior Use Of An Inaccessible Invention: Is It Disclosure?

    Canada’s laws provide a one-year grace period for public disclosures by the applicant (or by a person who obtained knowledge of an invention from the applicant) calculated from the Canadian filing date.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Protecting Your IP Against Corporate Espionage

    In this presentation, Daniel Polonenko addresses ways to protect your IP against corporate espionage
    CanadaIntellectual Property
    Gowling WLG
    Gowling WLG
  • Video

    Session II – Accessing And Protecting Your Intellectual Property (Video)

    Your business generates all kinds of IP rights – from groundbreaking ideas to creative brand names to copyrighted materials. This session is designed to help you recognize,...
    CanadaIntellectual Property
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    Supreme Court Of Canada Leave Applications - November 2018

    Supreme Court of Canada denies Eli Lilly leave to appeal in olanzapine section 8 damages action.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Rejects The "Promise Doctrine"

    In a unanimous and relatively short decision, the Supreme Court of Canada firmly rejected the "Promise Doctrine", which has been frequently invoked to invalidate patents on the basis of a lack of utility.
    CanadaIntellectual Property
    Ridout & Maybee LLP
    Ridout & Maybee LLP
  • Article

    Supreme Court Of Canada Reserves Decision On Appeal Relating To The Patentability Of Methods Of Medical Treatment

    Over ten years have passed since the Federal Court of Appeal (FCA) flagged the patentability of methods of medical treatment as being worthy of full consideration by the Supreme Court of Canada. This issue has finally come before the Court.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Takes A Pass On Patented Drug Price Dispute

    The Board decision was quashed, and the case was sent back to the Board for redetermination.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada To Hear Landmark Pharmaceutical Section 8 Damages Case

    On October 30, 2014, the Supreme Court of Canada granted leave to Sanofi-Aventis’ application for leave to appeal a decision of the Federal Court of Appeal.
    CanadaIntellectual Property
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    Text Of CETA Finalized — Finally!

    The Government of Canada has announced that the text of CETA — the Comprehensive Economic and Trade Agreement between Canada and Europe — was finalized after many months of silence on the historic trade deal.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    The Amazon.Com Judgment: The Patentability Of The One-Click Method

    On November 24, 2011, the Federal Court of Appeal rendered its judgment in the case of "Canada (A.G.) v. Amazon.com, Inc." (2011 FCA 328) requiring the Commissioner of Patents to re-examine the patent application presented by Amazon.com in 1998, in a manner consistent with the Court’s reasons.
    CanadaIntellectual Property
    Lavery
    Lavery
  • Article

    The Benefits Of Registering A Patent In Canada

    Although we may not realize it, each day every one of us interacts with patented inventions. Our phones, cars, and computers contain hundreds of patented components.
    CanadaIntellectual Property
    MBM Intellectual Property Law
    MBM Intellectual Property Law
  • Article

    The Canadian Intellectual Property Office's COVID-19 Response

    Like many other jurisdictions, the Canadian Intellectual Property Office (CIPO) has implemented extensions of time for certain deadlines relating to patents...
    CanadaIntellectual Property
    Aird & Berlis LLP
    Aird & Berlis LLP
  • Article

    The Canadian Intellectual Property Office Extends Deadlines Until April 1st Due To The Pandemic

    The coronavirus pandemic is having a significant impact on our personal lives, our countries and our economies! Canada's Intellectual Property Office is no exception.
    CanadaIntellectual Property
    Fasken
    Fasken
  • Article

    The Challenges Of Obtaining Summary Judgment

    In Reinhard Delp v. Fresh Headies Internet Sales Ltd. et al., 2011 FC 1228, the Federal Court considered a motion for summary judgment brought by two of five defendants seeking dismissal of a patent infringement action brought against them.
    CanadaIntellectual Property
    Heenan Blaikie LLP
    Heenan Blaikie LLP
  • Article

    The IP Dimensions Of 3D Printing: A Recent Decision

    There has been much speculation about the impact of 3D printing on the enforcement of IP rights. But very few decisions.
    CanadaIntellectual Property
    Field Law
    Field Law
  • Article

    The Supreme Court Of Canada Grants Leave To Appeal In The Plavix Case

    The Supreme Court of Canada announced today that it has granted leave to appeal to Apotex Inc. from the Federal Court of Appeal (FCA) in the patent case Sanofi-Aventis v. Apotex Inc. (reported here), in which the FCA allowed Sanofi’s action for infringement and dismissed Apotex’s action for impeachment (reported here).
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Trade Dress Updates: "Beauty" Does Not Cut It

    A recent decision of the US Federal Court (see: Apple, Inc. v. Samsung Electronics Co., Ltd. May 18, 2015) reviewed the jury decision in Apple's famous infringement lawsuit against Samsung.
    CanadaIntellectual Property
    Field Law
    Field Law
  • Article

    Trademark Law: Change In Practice Regarding Extensions Of Time In Examination

    On January 17, 2020, the Trademarks Branch of the Canadian Intellectual Property Office ("CIPO") issued a new practice notice with regard to requesting extensions
    CanadaIntellectual Property
    McMillan LLP
    McMillan LLP
  • Showing 561–580 of 4269 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics